SCHEMBL24201098

SCHEMBL24201098

O=C(O)COCCOCCOCCC(=O)OC12CC3CC4CC(C1)C2(C4)C3

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24201081 1.00 EPHX2 (0.31) EPHX2
SCHEMBL24201326 0.97 EPHX2 (0.32) EPHX2
SCHEMBL24201095 0.93 EPHX2 (0.32) EPHX2
SCHEMBL24201102 0.93 EPHX2 (0.32) EPHX2
SCHEMBL24201320 0.91 EPHX2 (0.33) EPHX2
SCHEMBL24201130 0.85 EPHX2 (0.33) EPHX2
SCHEMBL24201269 0.85 EPHX2 (0.33) EPHX2
SCHEMBL24201089 0.83 EPHX2 (0.34) EPHX2
SCHEMBL24201283 0.82 OPRK1 (0.30)
SCHEMBL24201152 0.82 OPRK1 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3618833-B1 TRIPARTITE ANDROGEN RECEPTOR ELIMINATORS, METHODS AND USES THEREOF SPG THERAPEUTICS INC (US) 2022-01-19 EP disclosed